« Previous Next » Fertility and Sterility
Volume 77, Issue 4 , Pages 660-665 , April 2002

Female androgen insufficiency: the princeton consensus statement on definition, classification, and assessment

Gloria Bachmann, M.D.
- Robert Wood Johnson Medical School, Women’s Health Institute, New Brunswick, New Jersey, USA
John Bancroft, M.D.
- The Kinsey Institute, Indiana University, Bloomington, Indiana, USA
Glenn Braunstein, M.D.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA
Henry Burger, M.D.
- Department of Medicine, Monash University, East Melbourne, Australia
Susan Davis, M.D.
- Jean Hailes Medical Centre, Clayton, Victoria, Australia
Lorraine Dennerstein, M.D.
- Office for Gender and Health, Royal Melbourne Hospital, Victoria, Australia
Irwin Goldstein, M.D.
- Department of Urology, Boston University Medical Center, Boston, Massachusetts, USA
Andre Guay, M.D.
- Center for Sexual Function, Lahey Clinic, Peabody, Massachusetts, USA
Sandra Leiblum, Ph.D.
- Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
Rogerio Lobo, M.D.
- Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
Morris Notelovitz, M.D.
- Consultant, Adult Women’s Medicine, Gainesville, Florida, USA
Raymond Rosen, Ph.D.
- Reprint requests: Raymond C. Rosen, Ph.D., Department of Psychiatry, Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway NJ 08854 USA (FAX: 732-235-4485)
- Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
Philip Sarrel, M.D.
- Yale University Health Services, New Haven, Connecticut, USA
Barbara Sherwin, Ph.D.
- Department of Psychology, McGill University, Montreal, Canada
James Simon, M.D.
- Women’s Health Research Center, George Washington University, Washington DC, USA
Evan Simpson, Ph.D.
- Prince Henry’s Institute of Medical Research, Monash Medical Center, Clayton, Victoria, Australia
Jan Shifren, M.D.
- Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital, Boston, Massachusetts, USA
Richard Spark, M.D.
- Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts, USA
Abdul Traish, Ph.D.
- Center for Advanced Biomedical Research, Boston University School of Medicine, Boston, Massachusetts, USA

Received 16 October 2001 ,Revised 4 January 2002 ,Accepted 4 January 2002.

References

Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 1974;39:340–346
- MEDLINE
- CrossRef
Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 1986;15:213–227
- MEDLINE
- CrossRef
Luu-The V, Dufort I, Pelletier G, Labrie F. Type 5 17 beta-hydroxysteroid dehydrogenase (its role in the formation of androgens in women). Molecul Cell Endocrinol. 2001;171:77–82
Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 1997;82:3498–3505
- MEDLINE
- CrossRef
Burger HG. Androgen production in women. Fertil Steril. 2002;4(Suppl 4):S3–S5
Simpson ER. Aromatization of androgens in women (current concepts and findings). Fertil Steril. 2002;4(Suppl 4):S6–S10
Shifren JL. Androgen deficiency in the oophorectomized woman. Fertil Steril. 2002;4(Suppl 4):S60–S62
Davis SR. When to suspect androgen deficiency other than at menopause. Fertil Steril. 2002;4(Suppl 4):S68–S71
Sarrel PM. Androgen deficiency (menopause and estrogen-related factors). Fertil Steril. 2002;4(Suppl 4):S63–S67
Simon JA. Estrogen replacement therapy (effects on the endogenous androgen milieu). Fertil Steril. 2002;4(Suppl 4):S77–S82
Spark RF. Dehydroepiandrosterone (a springboard hormone for female sexuality). Fertil Steril. 2002;4(Suppl 4):S19–S25
Bancroft J. Sexual effects of androgens in women (some theoretical considerations). Fertil Steril. 2002;4(Suppl 4):S55–S59